BENZIMIDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS
申请人:Janssen Pharmaceutica NV
公开号:US20170057929A1
公开(公告)日:2017-03-02
The present invention is directed to benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions mediated by the CB-1 receptor; more particularly, use in the treatment of disorders and conditions responsive to inverse agonism of the CB-1 receptor. More particularly, the compounds of the present invention are useful in the treatment of metabolic disorders.